3 weeks Wall Street Analysts Believe Urogen Pharma (URGN) Could Rally 209.92%: Here’s is How to Trade Zacks
The mean of analysts’ price targets for Urogen Pharma (URGN) points to a 209.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
X